Article thumbnail

Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef

By Christopher M Coleman, Paul Spearman and Li Wu
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). Affabris E, Federico M: HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation.
  2. (2006). AL: HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells.
  3. (2006). Amara A: Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
  4. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.
  5. (2009). Antiviral activity of the interferon-induced cellular protein BST-2/tetherin. AIDS Res Hum Retroviruses
  6. (1995). Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.
  7. (2009). AV: Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism.
  8. (2002). B: Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells.
  9. (2009). Bieniasz P: Human immunodeficiency virus, restriction factors, and interferon.
  10. (2007). Bieniasz PD: An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe
  11. (2009). Bieniasz PD: Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell
  12. (2008). Bieniasz PD: Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature
  13. (2006). Bone marrow stromal cell antigen 2 is a specific marker of type I IFNproducing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation.
  14. (2010). by sequestration in a perinuclear compartment. Retrovirology
  15. (2005). Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol
  16. (2007). Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection.
  17. (2009). Comparative study on the effect of human BST-2/Tetherin on HIV-1 release in cells of various species. Retrovirology
  18. (2009). DT: Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog
  19. (2010). EA: Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology
  20. (2009). EA: Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol
  21. (2005). Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.
  22. (2002). Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells.
  23. (2011). et al: HIV infection of dendritic cells subverts the interferon induction pathway via IRF1 and inhibits type 1 interferon production. Blood
  24. (2009). et al: HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe
  25. (2004). et al: Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood
  26. (2006). et al: Innate Sensing of HIVInfected Cells.
  27. (2009). et al: Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.
  28. (2009). et al: Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe
  29. (2010). F: Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in Coleman et al. Retrovirology 2011, 8:26 Page 17 of 18macrophages, but not in ex vivo human lymphoid tissue. Retrovirology
  30. (1989). Fauci AS: Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science
  31. (2010). Fruh K: The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog
  32. (2007). Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells.
  33. (2010). Guatelli JC: BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol
  34. (2009). Hatziioannou T: Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe
  35. (2008). HIV traffics through a specialized, surfaceaccessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog
  36. (2003). Hope TJ: Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science
  37. (2002). Hope TJ: Visualization of the intracellular behavior of HIV in living cells.
  38. (2010). Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog
  39. (2005). Inoue S: A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons. Biochem Biophys Res Commun
  40. (2009). Intercellular Adhesion Molecule (ICAM)-1, But Not ICAM-2 and -3, Is Important for Dendritic Cell-mediated Human Immunodeficiency Virus Type-1 Transmission.
  41. (2006). KewalRamani VN: Dendritic-cell interactions with HIV: infection and viral dissemination. Nat Rev Immunol
  42. (2002). KewalRamani VN: Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission.
  43. (2010). Krausslich HG: CD317/tetherin is enriched in the HIV1 envelope and downregulated from the plasma membrane upon virus infection.
  44. (2007). L: CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J Virol
  45. (2010). Littman DR: A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature
  46. (2008). Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells. Virology
  47. (2010). Malim MH: Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.
  48. (2009). Malim MH: Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets.
  49. (2007). MJ: Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity
  50. (2001). Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology
  51. (2010). O: Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog
  52. (2010). Paludan SR: Innate immune recognition and activation during HIV infection. Retrovirology
  53. (2009). Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.
  54. (2008). Productive infection of human immunodeficiency virus type 1 in dendritic cells requires fusionmediated viral entry. Virology
  55. (1995). Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
  56. (2008). Setting the stage: host invasion by HIV. Nat Rev Immunol
  57. (2010). SJ: Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells.
  58. (2006). SM: Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.
  59. (2006). Takaori-Kondo A, et al: Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem Biophys Res Commun
  60. (2011). Tetherin and Its Viral Antagonists.
  61. (2008). The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe
  62. (2009). Towers GJ: Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc Natl Acad Sci USA
  63. (2006). V: APOBEC3G/3F mediates intrinsic resistance of monocytederived dendritic cells to HIV-1 infection.
  64. (2005). V: HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic
  65. (2009). V: HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog
  66. (2009). Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci USA
  67. (2010). Wainberg MA: Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology
  68. (2007). WC: In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog
  69. (2009). Wu L: HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology
  70. Wu L: HIV-1 interactions with cells: from viral binding to cellcell transmission.